BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7929796)

  • 1. The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres.
    McKillop DF; Fortune NS; Ranatunga KW; Geeves MA
    J Muscle Res Cell Motil; 1994 Jun; 15(3):309-18. PubMed ID: 7929796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle.
    Higuchi H; Takemori S
    J Biochem; 1989 Apr; 105(4):638-43. PubMed ID: 2527229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detachment of low-force bridges contributes to the rapid tension transients of skinned rabbit skeletal muscle fibres.
    Seow CY; Shroff SG; Ford LE
    J Physiol; 1997 May; 501 ( Pt 1)(Pt 1):149-64. PubMed ID: 9175000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 2,3-butanedione monoxime on myosin and myofibrillar ATPases. An example of an uncompetitive inhibitor.
    Herrmann C; Wray J; Travers F; Barman T
    Biochemistry; 1992 Dec; 31(48):12227-32. PubMed ID: 1457420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vanadate, phosphate and 2,3-butanedione monoxime (BDM) on skinned molluscan catch muscle.
    Galler S; Höpflinger MC; Andruchov O; Andruchova O; Grassberger H
    Pflugers Arch; 2005 Jan; 449(4):372-83. PubMed ID: 15490227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle cross-bridges bound to actin are disordered in the presence of 2,3-butanedione monoxime.
    Zhao L; Naber N; Cooke R
    Biophys J; 1995 May; 68(5):1980-90. PubMed ID: 7612840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3-Butanedione monoxime (BDM) as a myosin inhibitor.
    Ostap EM
    J Muscle Res Cell Motil; 2002; 23(4):305-8. PubMed ID: 12630704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skinned cardiac fibres of diabetic rats: contractile activation and effects of 2,3-butanedione monoxime (BDM) and caffeine.
    Khandoudi N; Guo AC; Chesnais M; Feuvray D
    Cardiovasc Res; 1993 Mar; 27(3):447-52. PubMed ID: 8490945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cross-bridge interaction by 2,3-butanedione monoxime in human ventricular myocardium.
    Brixius K; Schwinger RH
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):440-4. PubMed ID: 10763860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple actions of 2,3-butanedione monoxime on contractile activation in frog twitch fibres.
    Hui CS; Maylie J
    J Physiol; 1991 Oct; 442():527-49. PubMed ID: 1798041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 2,3-butanedione monoxime on activation of contraction and crossbridge kinetics in intact and chemically skinned smooth muscle fibres from guinea pig taenia coli.
    Osterman A; Arner A; Malmqvist U
    J Muscle Res Cell Motil; 1993 Apr; 14(2):186-94. PubMed ID: 8315022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP utilization for calcium uptake and force production in different types of human skeletal muscle fibres.
    Szentesi P; Zaremba R; van Mechelen W; Stienen GJ
    J Physiol; 2001 Mar; 531(Pt 2):393-403. PubMed ID: 11230512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDM affects nucleotide binding and force generation steps of the cross-bridge cycle in rabbit psoas muscle fibers.
    Zhao Y; Kawai M
    Am J Physiol; 1994 Feb; 266(2 Pt 1):C437-47. PubMed ID: 8141258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BDM compared with P(i) and low Ca2+ in the cross-bridge reaction initiated by flash photolysis of caged ATP.
    Kagawa K; Horiuti K; Yamada K
    Biophys J; 1995 Dec; 69(6):2590-600. PubMed ID: 8599666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by 2,3-butanedione-monoxime of mitochondrial ADP-dependent respiration and muscle contraction.
    Mojon D; Zhang W; Oetliker H
    Biochem Mol Biol Int; 1993 Nov; 31(3):501-7. PubMed ID: 8118426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 2,3-butanedione monoxime on the contractile activation properties of fast- and slow-twitch rat muscle fibres.
    Fryer MW; Neering IR; Stephenson DG
    J Physiol; 1988 Dec; 407():53-75. PubMed ID: 3256625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effect of vanadate on the binding of myosin-subfragment-1.ADP to actin and on actomyosin subfragment 1 ATPase activity.
    Smith SJ; Eisenberg E
    Eur J Biochem; 1990 Oct; 193(1):69-73. PubMed ID: 2146116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of nucleoside triphosphate cleavage and phosphate release steps by associated rabbit skeletal actomyosin, measured using a novel fluorescent probe for phosphate.
    White HD; Belknap B; Webb MR
    Biochemistry; 1997 Sep; 36(39):11828-36. PubMed ID: 9305974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDM (2,3-butanedione monoxime), an inhibitor of myosin-actin interaction, suppresses myofibrillogenesis in skeletal muscle cells in culture.
    Soeno Y; Shimada Y; Obinata T
    Cell Tissue Res; 1999 Feb; 295(2):307-16. PubMed ID: 9931377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 2,3-butanedione monoxime on the crossbridge kinetics in frog single muscle fibres.
    Bagni MA; Cecchi G; Colomo F; Garzella P
    J Muscle Res Cell Motil; 1992 Oct; 13(5):516-22. PubMed ID: 1460080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.